Keywords
How to Cite
Abstract
Transposition of the great arteries (TGA) is a congenital heart defect in which the two main arteries that exit the heart are reversed. This condition severely compromises blood circulation, preventing oxygenated blood from the lungs from being properly distributed throughout the body.
Methodology: The selection of articles was based on specific inclusion criteria such as relevance to the topic, methodological quality, and contribution to the understanding of the challenges and advancements in the treatment of TGA. The articles were critically analyzed to identify trends, knowledge gaps, and areas of controversy.
Results: The arterial switch operation, also known as the Jatene procedure, is considered the definitive treatment for TGA. Introduced by Adib Jatene in 1975, this technique revolutionized TGA treatment by repositioning the main arteries and reimplanting the coronary arteries. Although this surgery has significantly increased long-term survival rates, its technical complexity presents considerable challenges.
Conclusion: In conclusion, the treatment of transposition of the great arteries has advanced significantly since the early days of high neonatal mortality rates. The arterial switch operation has revolutionized treatment, providing better survival rates and improved quality of life for patients.
References
BERKES, A. et al. Measuringhealth-relatedqualityoflife in Hungarianchildrenwithheartdisease: psychometricpropertiesoftheHungarianversionofthePediatricQualityof Life Inventory. 4.0 Generic Core ScalesandtheCardiac Module. Health andQualityof Life Outcomes, v. 8, p. 1-12, 2010.
CHANNICK, R.N., Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, et al. Effectsofthe dual endothelinreceptorantagonistbosentan in patientswithpulmonaryhypertension: a randomised placebo-controlledstudy. Lancet, p. 1119-1123, 2001. FUSTER, V.; STEELE, P.
M.; EDWARDS, W. D.; GERSH, B. J.; MCGOON, M. D., FRYE, R. L.
Primarypulmonaryhypertension: natural historyandtheimportanceofthrombosis. Circulation, p. 580-587, 1984.
FRISHMAN W.; SILVERMAN, R. Clinicalpharmacologyofthe new betaadrenergicblockingdrugs. Part 2. Physiologicandmetaboliceffects. Am Heart J, p. 797-807.
ARRUDA FILHO, M. B., et al. Anomalia de Ebstein em paciente adulto: valvuloplastia modificada para correção de insuficiência tricúspide.Revista Brasileira de Cirurgia Cardiovascular, vol. 17, suplemento 2, p. 24-28, 2002.
ATTENHOFER,Jost C. H., CONNOLY, H. M., EDWARDS, W. D., HAYES, D., WARNES C., DANIELSON G. K.Ebstein’sAnomaly – review of a multifaceted congenital cardiaccondition.SwissMedWkly, p. 269-281, 2005.
BROWN ML, et al. The outcomesofoperations for 539 patientswithEbsteinanomaly.The JournalofThoracicand Cardiovascular Surgery, vol. 135, p. 1120-36, 2008.
WEBB, G. D., et al. Doença Cardíaca Congênita.Tratado de Doenças Cardiovasculares, 7ª ed, Elsevier Ltda, Rio de Janeiro, cap. 56, vol. 2, p. 1489-552, 2006.
MORETTI, Marcelo Pasqual; SCHULZ, Júlio César; MORETTI, Miguel;ARAÚJO,Danyella; CESCONETTO, Bruna.Associação da Anomalia de Ebstein com a Síndrome de Wolff-Parkinson-White: relato de caso. Arquivos Catarinenses de Medicina, vol. 40, n° 4,2011.
SANTOS, M. A., AZEVEDO, V. M. P. Coarctação da Aorta. Anomalia congênita com novas perspectivas de tratamento. ArqBrasCardiol, p. 340-346, 2003.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Míriam Gonçalves de Castro, Luiza Galvão Fernandes Lima, Gabriela Luiza Nicareta, Mateus Gomes da Silva Serra , Elisa Emanoelle Vazquez Nicareta , Renato Pessoa Da Silva Cruz , Suele Amorim de Souza , Sayuri Beatriz Paiva Lee , Carine Fontes Guerra , Pedro Henrique Paes Alves , Maria Laura Vasconcelos Moreira Lopes de Goes , Arthur Pereira Miranda